+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Cartilage Degeneration Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Procedure Type; Application; and End User and Country - Regional Analysis and Market Forecasts by Procedure Type, Application and End User

  • ID: 5180780
  • Report
  • September 2020
  • Region: North America
  • 113 pages
  • The Insight Partners
UP TO OFF
until Jan 15th 2021

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • CONMED Corporation
  • Stryker Corporation
  • Zimmer Biomet
  • MORE
The North America cartilage degeneration market is expected to reach US$ 6,998.45 million by 2027 from US$ 4,889.27 million in 2019; it is estimated to grow at a CAGR of 4.7% from 2020 to 2027.

The cartilage degeneration market is growing primarily due to the increasing prevalence of sports injuries and obesity in North America. However, the high cost of cartilage therapies is restraining the growth of the market. Nevertheless, growing number of product approvals and rising emphasis on regenerative medicines are likely to fuel the growth of the cartilage degeneration market during the forecast period.

Degeneration of cartilage can lead to pain and chronic inflammation in joints of a human body. Furthermore, damaged cartilage can potentially influence the quality of a patient’s life. Continuous research and developments are innovating new techniques and methodologies to deal with damaged cartilages. A few of these techniques comprise joint replacement, cell therapies, and chondroplasty.

Athletes and players frequently get injured during sports activities. According to a study published by Stanford Children’s Health in 2020, an estimated 30 million children and teenagers participate in sports annually in the US. Further, the most common injuries observed among children and teenagers are sprains and strains. The sports injuries have significant potential to damage cartilage and ligaments. Thus, an increasing number of incidents of sports injuries among players and athletes is anticipated to drive the growth of the cartilage degeneration market during the forecast period.

The growing number of participants in sports leads to increasing possibilities of sports injuries. According to a study published by the National Federation of State High School Associations (NFHS), during 2018−2019, soccer, wrestling, and tennis witnessed significant growth in participation by high school boys in the US. Such an increasing number of participants in sports is projected to drive the prevalence of cartilage injuries, which will eventually accelerate the growth of the North America cartilage regeneration market by 2027.

As the COVID-19 pandemic continues to unfold in the North American countries, medical device companies are finding difficulties in managing their operations. Many companies operating in the US and offering products for cartilage regeneration have been affected by the effects of COVID-19 crisis. The pandemic has disrupted and restricted the abilities of the companies to distribute products as well as led to temporary closures of the facilities. Also, hospitals have postponed or canceled elective surgeries to free-up limited space and transform operating rooms into intensive care units. These factors associated with the current pandemic are affecting the growth of the North America cartilage degeneration market.

The knee segment accounted for the largest share of the market in 2019. According to a study published in an online newspaper, one in four adults suffers from chronic knee pain. The growth of the knee segment is attributed to the increasing prevalence of knee injuries. Furthermore, the increasing awareness of benefits provided by cartilage repair is anticipated to drive the growth of the knee segment.

The major secondary sources associated with the North America cartilage degeneration market report are World Health Organization (WHO), American Academy of Orthopaedic Surgeons (AAOS), Washington University Orthopedics, Agency for Healthcare Research and Quality, Centers of Disease Control and Prevention (CDC), National Federation of State High School Associations (NFHS), Arthritis Foundation 2020 and others.

Reasons to Buy
  • Understand the Northe America cartilage degeneration market landscape and identify cartilage degeneration segments that are most likely to guarantee a strong return.
  • Stay ahead of the race by comprehending the ever-changing competitive landscape in the region.
  • Efficiently plan mergers and acquisitions, and partnership deals in the North America cartilage degeneration market by identifying segments with the most promising probable sales.
  • Take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments.
  • Obtain revenue forecast of market based on various segments for the period 2019-2027.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • CONMED Corporation
  • Stryker Corporation
  • Zimmer Biomet
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 North America Cartilage Degeneration Market - By Procedure Type
1.3.2 North America Cartilage Degeneration Market - By Application
1.3.3 North America Cartilage Degeneration Market- By End User
1.3.4 North America Cartilage Degeneration Market - By Country

2. North America Cartilage Degeneration Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Cartilage Degeneration Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cartilage Degeneration Market - North America PEST Analysis
4.3 Expert Opinion

5. North America Cartilage Degeneration Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Number of Sports Injuries
5.1.2 Increasing Prevalence of Obesity
5.2 Key Market Restraints
5.2.1 High Cost of Cartilage Repair Therapies
5.3 Key Market Opportunities
5.3.1 Growing Number of Product Approvals and Developments
5.4 Future Trends
5.4.1 Rising Emphasis on Regenerative Medicines
5.5 Impact analysis

6. Cartilage Degeneration Market - North America Analysis
6.1 North America Cartilage Degeneration Market Revenue Forecasts and Analysis

7. North America Cartilage Degeneration Market Analysis and Forecasts To 2027 - By Procedure Type
7.1 Overview
7.2 North America Cartilage Degeneration Market, By Procedure Type 2019 & 2027 (%)
7.2.1 North America Cartilage Degeneration Market Revenue and Forecasts to 2027, By Procedure Type (US$ Mn)
7.3 Osteochondral Transplant
7.3.1 Overview
7.3.2 North America Osteochondral Transplant Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Chondroplasty
7.4.1 Overview
7.4.2 North America Chondroplasty Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Joint Replacement
7.5.1 Overview
7.5.2 North America Joint Replacement Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Meniscus Transplants
7.6.1 Overview
7.6.2 North America Meniscus Transplants Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Cell-based Cartilage Resurfacing
7.7.1 Overview
7.7.2 North America Cell-based Cartilage Resurfacing Market Revenue and Forecast to 2027 (US$ Mn)
7.8 Other Procedures
7.8.1 Overview
7.8.2 North America Other Procedures Market Revenue and Forecast to 2027 (US$ Mn)

8. North America Cartilage Degeneration Market Analysis and Forecasts To 2027 - By Application
8.1 Overview
8.2 North America Cartilage Degeneration Market, By Application 2019 & 2027 (%)
8.2.1 North America Cartilage Degeneration Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Knee
8.3.1 Overview
8.3.2 North America Knee Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Hip
8.4.1 Overview
8.4.2 North America Hip Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Other Applications
8.5.1 Overview
8.5.2 North America Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)

9. North America Cartilage Degeneration Market Analysis - By End-User
9.1 Overview
9.2 North America Cartilage Degeneration Market, By End-User 2019-2027 (%)
9.2.1 North America Cartilage Degeneration Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
9.3 Hospitals and Specialty Centres
9.3.1 Overview
9.3.2 North America Hospitals and Specialty Centres Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Ambulatory Surgical Centres
9.4.1 Overview
9.4.2 North America Ambulatory Surgical Centres Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 North America Academic and Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)

10. Cartilage degeneration Market Revenue and Forecasts To 2027 - Geographical Analysis
10.1 North America Cartilage degeneration Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 North America: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Cartilage Degeneration Market, by Procedure Type, 2018-2027 (USD Million)
10.1.4 North America: Cartilage Degeneration Market, by Application, 2018-2027 (USD Million)
10.1.5 North America: Cartilage Degeneration Market, by End User, 2018-2027 (USD Million)
10.1.6 North America: Cartilage Degeneration Market, by Country, 2019& 2027 (%)
10.1.7 US: Cartilage Degeneration Market- Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Cartilage Degeneration Market, by Procedure Type, 2018-2027 (USD Million)
10.1.7.3 US: Cartilage Degeneration Market, by Application, 2018-2027 (USD Million)
10.1.7.4 US: Cartilage Degeneration Market, by End User, 2018-2027 (USD Million)
10.1.8 Canada: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Cartilage Degeneration Market, by Procedure Type, 2018-2027 (USD Million)
10.1.8.3 Canada: Cartilage Degeneration Market, by Application, 2018-2027 (USD Million)
10.1.8.4 Canada: Cartilage Degeneration Market, by End User, 2018-2027 (USD Million)
10.1.9 Mexico: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Cartilage Degeneration Market, by Procedure Type - Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Cartilage Degeneration Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico Cartilage Degeneration Market, by End User - Revenue and Forecast to 2027 (USD Million)

11. Impact of COVID-19 Pandemic on North America Cartilage degeneration Market
11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Company Profiles
12.1 Zimmer Biomet
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Stryker Corporation
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Johnson and Johnson Services, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 CONMED Corporation
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Anika Therapeutics, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Arthrex, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
Note: Product cover images may vary from those shown
  • Zimmer Biomet
  • Stryker Corporation
  • Johnson and Johnson Services, Inc.
  • CONMED Corporation
  • Arthrex, Inc.
  • Anika Therapeutics, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll